Mitchell Stern
Dresner Partners
IGENOMIX
Deal Type
Company sale
Sector
Healthcare
Completion Date
12th September 2016
Deal Value
Not disclosed
Company Background
IGENOMIX was created in 2011 when it was spun-out from Instituto Valenciano de Infertilidad (IVI). Today it is one of the world’s leading providers of advanced services in reproductive genetics, operating from eight laboratories worldwide.
Deal Summary
Dresner Partners collaborated as an advisor to Arcano Group of Madrid (Spain) on the recent sale of IGENOMIX, a leading provider of genetic testing services for reproductive health patients and clinics, to Charme Capital Partners, Amadeus Capital Partners, Aleph Capital, and Graham Snudden. Terms of the transaction were not disclosed.
